• Search History (Register)
  • MeSH Browser

Welcome to the international HTA database


Showing [20001 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2008     German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI) [Federal structures and associated behavioural interventions in prevention of cigarette smoking]
2010     Institute for Clinical Effectiveness and Health Policy (IECS) [Fecal calprotectin: diagnostic marker and treatment assessment in bowel inflammatory disease]
2016     Institut national d'excellence en sante et en services sociaux (INESSS) [Feasibility and appropriateness of implementing satellite radiotherapy centres equipped with a single linear accelerator]
2021     Swedish Agency for Health Technology Assessment and Assessment of Social Services (SBU) [Fear of childbirth, depression and anxiety during pregnancy]
2009     The Netherlands Organisation for Health Research and Development (ZonMw) [FDG-PET for avoidance of futile direct laryngoscopies under general anaesthesia with taking of biopsies in patients with suspicion on recurrent laryngeal carcinoma after radiotherapy]
2010     Committee for New Health Technology Assessment (CNHTA) [FBN1 exon deletion test[MLPA]]
2005     Danish Centre for Evaluation and Health Technology Assessment (DACEHTA) [Fast-track colonic surgery: a health technology assessment]
2006     Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Familial hypercholesterolemia: evaluation of genetic screening by DNA microarrays]
2012     German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI) [Falls prevention for the elderly]
2012     German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI) [Falls prevention for the elderly]
2013     Institut national d'excellence en sante et en services sociaux (INESSS) [Falls in patients living in health care facilities (short- and long-term care)]
2010     The Netherlands Organisation for Health Research and Development (ZonMw) [Falling in line with the guidelines. Development and pilot testing of an implementation strategy to increase physiotherapists' adherence to evidence-based guidelines for patients with low back pain; a planned, systematic, and theory-based approach]
2011     Health Council of the Netherlands Gezondheidsraad (GR) [Fair compensation. Consideration of a proposal to give live kidney donors priority for transplants]
2017     Andalusian Health Technology Assessment Area (AETSA) [Faecal microbiota transplant for recurrent clostridium difficile infection. Up-date]
2008     Committee for New Health Technology Assessment (CNHTA) [Facioscapulohumeral muscular dystrophy, D4Z4 analysis, PFGE/Southern Blot]
2014     Institut national d'excellence en sante et en services sociaux (INESSS) [Facility planning and infection prevention: sanitary facilities in specialized care rooms and cubicles]
2009     Committee for New Health Technology Assessment (CNHTA) [F7 gene, mutation[sequencing]]
2009     Committee for New Health Technology Assessment (CNHTA) [F12 gene, mutation[sequencing]]
2019     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Ezetimibe for the prevention of cardiovascular events - Rapid report]
2008     Committee for New Health Technology Assessment (CNHTA) [Eyeball brachytherapy]
2021     Institute for Clinical Effectiveness and Health Policy (IECS) [Eye controlled speech generating device]
2009     Committee for New Health Technology Assessment (CNHTA) [Extremely low temperature cool chamber]
2018     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Extract from Cannabis sativa (spasticity due to multiple sclerosis) - Benefit assessment according to §35a Social Code Book V (expiry of the decision)]
2021     Institute for Clinical Effectiveness and Health Policy (IECS) [Extracranial stereotactic body radiotherapy in oligometastasis]
2004     Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Extracorporeal shock-wave treatment in orthopedics and rehabilitation. Update]
2018     Institute for Clinical Effectiveness and Health Policy (IECS) [Extracorporeal shock wave therapy in musculoskeletal disorders]
2012     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) [Extracorporeal shock wave therapy (ESWT) for the treatment of delayed union or non-union of fractures]
2017     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Extracorporeal shock wave therapy (ESWT) for heel pain]
2009     Committee for New Health Technology Assessment (CNHTA) [Extracorporeal photopheresis]
2016     Institut national d'excellence en sante et en services sociaux (INESSS) [Extracorporeal photopheresis: main indications and implementation parameters]
2021     Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Extracorporeal membrane oxygenation for out-of-hospital cardiac arrest]
2009     Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Extracorporeal liver support of liver failure by means of Prometheus system]
2010     Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) [Extracorporeal High-Intensity Focused Ultrasound (HIFU) in solid tumours]
2008     Basque Office for Health Technology Assessment (OSTEBA) [External review and validation of methodological instruments for the critical reading and summary of scientific evidence]
2007     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) [External manual. Part 1]
2003     Danish Centre for Evaluation and Health Technology Assessment (DACEHTA) [External evaluation of DACEHTA]
2010     Agence d'évaluation des technologies et des modes d'intervention en santé (AETMIS) [External evaluation of cancer care organization and delivery: review of experiences relevant to the cancer team evaluation and designation process in Québec]
2012     Andalusian Health Technology Assessment Area (AETSA) [Extended neonatal screening for lysosomal diseases by mass spectrometry]
2018     Institute for Clinical Effectiveness and Health Policy (IECS) [Extended adjuvant endocrine therapy in breast cancer]
2006     Andalusian Health Technology Assessment Area (AETSA) [Expulsion stage of delivery: comparison of upright versus lying down positions for childbirth, through maternal and foetal outcomes]
2016     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Exploratory examination of the need for revision of the DMP "coronary heart disease"]
2020     National Committee for Technology Incorporation (CONITEC) [Expansion of the use of sirolimus for the treatment of adult patients with lymphangioleiomyomatosis]
2008     The Netherlands Organisation for Health Research and Development (ZonMw) [Expanding thrombolysis in acute ischemic stroke: organizing effective and efficient daily care in The Netherlands]
2009     The Netherlands Organisation for Health Research and Development (ZonMw) [Exercise therapy in patients with peripheral arterial disease: the costs and effectiveness of physiotherapeutic supervision with or without therapy feedback versus a 'go home and walk' advice]
2008     The Netherlands Organisation for Health Research and Development (ZonMw) [Exercise therapy for patellofemoral pain syndrome: a randomised clinical trial in general practice and sports medicine]
2011     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) [Exercise therapy (Krankengymnastik / Heilgymnastik) in physical medicine]
2020     National Committee for Technology Incorporation (CONITEC) [Exclusion of rifampicin for chemoprophylaxis for contacts of patients with Hansen´s disease]
2015     Institute for Clinical Effectiveness and Health Policy (IECS) [Exantia® tissue bulking agent for the treatment of fecal incontinence]
2019     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Examination of the usability of the scientific use files of the ZfKD in the framework of the determination of the SHI target population]
2010     Basque Office for Health Technology Assessment (OSTEBA) [Examination of barriers and facilitators for the implementation of clinical practice guidelines: a Delphi study]
2012     Danish Centre for Evaluation and Health Technology Assessment (DACEHTA) [Examination and treatment of older people after a fall – a health technology assessment]
2018     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Evolocumab (primary hypercholesterolaemia or mixed dyslipidaemia) - Benefit assessment according to §35a Social Code Book V (new scientific findings)]
2022     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Evolocumab (hypercholesterolaemia) - Benefit assessment according to §35a Social Code Book V]
2015     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Evolocumab - Benefit assessment according to §35a Social Code Book V]
2015     Basque Office for Health Technology Assessment (OSTEBA) [Evidence-based recommendations for vascular access care]
2015     Basque Office for Health Technology Assessment (OSTEBA) [Evidence-based recommendations for fall prevention]
2021     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Evidence report for the S3 guideline on dementia: Technical support systems]
2021     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Evidence report for the S3 guideline on dementia: Structured information on the initial diagnosis]
2021     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Evidence report for the S3 guideline on dementia: Structural imaging]
2021     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Evidence report for the S3 guideline on dementia: Non-drug interventions for mild cognitive impairment and biomarker evidence]
2021     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Evidence report for the S3 guideline on dementia: Dementia care management]
2021     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Evidence report for the S3 guideline on dementia: Cognitive training / cognitive stimulation]
2021     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Evidence report for the S3 guideline on clinical nutrition in gastroenterology - Pancreas: timing of nutrition in acute pancreatitis]
2021     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Evidence report for the S3 guideline on clinical nutrition in gastroenterology - Pancreas: nutritional supplementation in acute pancreatitis]
2021     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Evidence report for the S3 guideline on clinical nutrition in gastroenterology - Pancreas: nutritional interventions in chronic pancreatitis]
2021     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Evidence report for the S3 guideline on clinical nutrition in gastroenterology - Pancreas: initial tube feeding in acute pancreatitis]
2021     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Evidence report for the S3 guideline on clinical nutrition in gastroenterology - Pancreas: initial nutrition in acute pancreatitis]
2012     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) [Evidence overview of therapeutic hypothermia]
2021     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Evidence on orphan drugs]
2016     Institut national d'excellence en sante et en services sociaux (INESSS) [Evidence brief on the measures related to the reimbursement of blood glucose test strips]
2011     Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) [Everolimus (Afinitor) for the treatment of renal cell carcinoma]
2007     The Netherlands Organisation for Health Research and Development (ZonMw) [Evaluation of vascular care in Alzheimer's disease]
2017     Basque Office for Health Technology Assessment (OSTEBA) [Evaluation of the utility and indication of prostate biopsies with image fusion – magnetic resonance and transrectal ultrasound]
2015     Basque Office for Health Technology Assessment (OSTEBA) [Evaluation of the use of the new tools 2.0 and the social web in the diffusion and dissemination of the products of the agencies and units of Health Technology Assessment]
1998     Andalusian Health Technology Assessment Area (AETSA) [Evaluation of the use of antidigoxin antibodies in the treatment of digitalis intoxication]
2021     Centre intégré universitaire de santé et de services sociaux de la Capitale-Nationale (CIUSSS) [Evaluation of the service offer from the Centre d'expertise pour les victimes de brûlures graves de l'est du Québec (CEVBGEQ) in relation to the use of pressure garments to treat scarring in severe burn patients]
2018     Basque Office for Health Technology Assessment (OSTEBA) [Evaluation of the scientific evidence on nipple-areola complex micropigmentation, requirements for its proper implementation and costs]
2010     The Netherlands Organisation for Health Research and Development (ZonMw) [Evaluation of the potential of real-time 3-dimensional echocardiography in the assessment of right ventricular function in adult congenital heart disease: comparison of RT-3D echo with MRI]
2012     Basque Office for Health Technology Assessment (OSTEBA) [Evaluation of the implementation of clinical guidelines in the Basque Country. Cluster randomized trial]
2011     National Evidence-based Healthcare Collaborating Agency (NECA) [Evaluation of the impact in inequality before and after the enhancement of health insurance coverage of cancer]
2012     Institut national d'excellence en sante et en services sociaux (INESSS) [Evaluation of the evidence on the HeartMate II and HeartWare ventricular assist devices for the treatment of chronic end-stage heart failure]
2005     Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Evaluation of the efficacy and safety of negative pressure in the treatment of chronic wounds]
2014     Basque Office for Health Technology Assessment (OSTEBA) [Evaluation of the effectiveness of psychological intervention in the first psychotic episode by multidisciplinary treatment]
2004     Danish Centre for Evaluation and Health Technology Assessment (DACEHTA) [Evaluation of the Danish National Cancer Action Plan - status and future monitoring - summary and proposals for focus areas]
2011     National Evidence-based Healthcare Collaborating Agency (NECA) [Evaluation of the change in medical services before and after the enhancement of health insurance coverage of cancer]
2003     Agence d'évaluation des technologies et des modes d'intervention en santé (AETMIS) [Evaluation of techniques for detecting breast implant rupture]
2011     Andalusian Health Technology Assessment Area (AETSA) [Evaluation of surrogate variables in oncology. Advanced and metastatic breast cancer]
2016     Institut national d'excellence en sante et en services sociaux (INESSS) [Evaluation of subcutaneous-lead implantable cardioverter-defibrillators]
2021     Norwegian Institute of Public Health (NIPH) [Evaluation of PD-L1 assays in urothelial carcinoma: a rapid HTA]
2007     German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI) [Evaluation of optical coherence tomography in the diagnosis of age related macular degeneration compared with fluorescence angiography]
2010     Haute Autorite de sante (HAS) [Evaluation of negative-pressure wound therapy]
2011     Secretaria de Ciencia, Tecnologia e Insumos Estrategicos, Departamento de Ciencia e Tecnologia (DECIT-CGATS ) [Evaluation of multiple technologies for chronic wounds and burns]
2009     German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI) [Evaluation of medical and health economic effectiveness of non-pharmacological secondary prevention of coronary heart disease]
2008     German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI) [Evaluation of medical and health economic effectiveness of bariatric surgery (obesity surgery) versus conservative strategies in adult patients with morbid obesity]
2009     The Netherlands Organisation for Health Research and Development (ZonMw) [Evaluation of l-caldesmon as biomarker for brain tumor monitoring]
2009     Finnish Office for Health Care Technology Assessment (Finohta) [Evaluation of implementation of foetal screening]
2016     Haute Autorite de sante (HAS) [Evaluation of gene amplification for diagnosis Herpesviridae infections (cytomegalovirus, herpes simplex virus and varicella-zoster) in people living with HIV]
2009     Agence d'évaluation des technologies et des modes d'intervention en santé (AETMIS) [Evaluation of ethylene oxide sterilant alternatives: plasma and ozone]
2014     Unidad de Evaluacion de Tecnologias Sanitarias (UETS) [Evaluation of efficiency of organizational models for stroke management (stroke units)]
2013     Unidad de Evaluacion de Tecnologias Sanitarias (UETS) [Evaluation of efficacy and safety of PET-CT (update)]